Targeting Integrins with safe small
BioMAS Ltd. is a clinical stage company, the only known company worldwide to focus on the invention, development and commercialization of tellurium based compounds. The Company’s lead molecules AS101 and SAS, are small tellurium based compounds developed for the treatment of various conditions.
The molecules developed by BioMAS have Integrin inhibitory properties based on their interaction with specific thiols. Integrins are emerging therapeutic targets in many human pathologies... More...
The Hebrew University of Jerusalem | Edmond J. Safra Campus, Givat Ram | High-Tech Village, POB 39106, Jerusalem | Israel 91390
Tel: +972-72-2204000, Fax: +972-72-2204008, E-mail: email@example.com